News|Articles|September 26, 2014
FDA and NIH Win Award for IP Licensing of Meningitis Vaccine
Author(s)Pharmaceutical Technology Editors
Partnership is awarded for licensing of low-cost vaccine for the treatment of bacterial meningitis.
Advertisement
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
